Breaking News

Lonza Joins Center for Continuous Manufacturing and Advanced Crystallization

Lonza will serve as a CMAC Translation to Industry Collaborator, reinforcing its commitment to advancing innovative manufacturing solutions.

By: Rachel Klemovitch

Assistant Editor

Lonza, a global development and manufacturing partner to the pharmaceutical and biotech markets, has joined CMAC, a center for medicines manufacturing research, to enhance its service offering for particle technologies and drug product development and manufacture.  CMAC is an international research hub with academic and industrial leaders in applied and pre-competitive research programs, based at the University of Strathclyde in Scotland. It aims to transform pharmaceutical manufacturing and ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters